Watchlist

Watchlist
Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences Corp. (AVXL)
Anavex's (AVXL) CEO Christopher Missling on Q4 2017 Results - Earnings Call (Transcript)
Anavex Life Sciences Corp. (AVXL) Q4 2017 Earnings Conference Call December 11, 2017 4:30 P.M. ET Executives Clayton Robertson - The Trout Group Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer Analysts Jason Helfste…
Anavex Life Sciences reports FY results
Anavex Life Sciences (NASDAQ: AVXL ): FY EPS of -$0.33 More news on: Anavex Life Sciences Corp., Earnings news and commentary, Healthcare stocks news, , Read more …
Anavex up 5% premarket on positive data on sigma-1 agonists
Thinly traded micro cap Anavex Life Sciences (NASDAQ: AVXL ) perks up 5% premarket on light volume on the heels of new data published in Neurotoxicity Research supporting the neuroprotective aspects of sigma-1 agonists, including pipeline candidates ANAVEX 2-73, ANAVEX 1-41 a…
Alzheimer's Disease: Anavex 2-73 And The Long Road Home
Of all the drugs currently being tested for Alzheimers disease, Anavex 2-73 ( AVXL ) -- by focusing on reducing and possibly reversing nitro-oxidative stress -- likely has the best chance of success. Despite this the company faces a number of challenges including skepticism regarding r…
Your Daily Pharma Scoop: Soliris New Indication, Gilead's NASH Data, What Keeps Synergy Down?
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service . Analysis of top Seeking Alpha coverage: Synergy Today we will discuss an article on Synerg…
Week 43 Breakout Forecast: Short-Term Picks To Give You An Edge
Week 43 Selections are as follows: Positive Acceleration Momentum Stocks This week I have selected 8 breakout stocks from the following sectors: 4 healthcare, 1 industrial goods, and 3 technology. I've included some background on stocks with interesting current news that may fu…
Your Daily Pharma Scoop: Johnson & Johnson's Mixed Signals, Celgene's Mongersen Failure, QURE's Hemophilia B Trial
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Johnson & Johnson Today we will discuss a set of…
Your Daily Pharma Scoop: Gilead's Brave New World, AZN's Lynparza SNDA, RXDX Entrectinib Shows Positive Results
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gileads CART approval Today we…
Your Daily Pharma Scoop: Everybody's Gilead Problem, Halozyme's Further Progress, Ziopharm's Gene Therapy
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Today we will discuss an articl…
Anavex Life Sciences (AVXL) Presents Analysis of ANAVEX 2-73 Phase 2a Data - Slideshow
The following slide deck was published by Anavex Life Sciences Corp. in conjunction with this Read more …
Premarket Gainers as of 9:05 am
INFI +44% on new data for IPI-549. More news on: Infinity Pharmaceuticals, Inc., Ardelyx, OncoSec Medical Incorporated, Stocks on the move, Read more …
Anavex Life Sciences Corp. (AVXL)